Zydus Wellness Makes First Global Buy, Acquires UK’s Comfort Click For £239 Million

The acquisition will mark Zydus’ foray into the fast-growing vitamins, minerals, and supplements (VMS) market.

Zydus Wellness shares surged nearly 9% on Monday, after the drugmaker completed its first overseas acquisition with the purchase of UK-based Comfort Click Limited (CCL) through its wholly owned subsidiary Alidac UK. The deal includes CCL and its subsidiaries in Ireland, the US, and India. The value of the agreement is £239 million.

At the time of writing, Zydus Wellness shares were up 7.6% at ₹2,172.5, having gained 11.6% so far this year.

Analyzing Deal Metrics

Comfort Click, which operates across the UK and Europe and is expanding in the US, reported revenues of £134 million for the year ending June 30, 2025, with a five-year CAGR of 57% and adjusted operating profit of £21 million.

“The global acquisition of Comfort Click, a leading player in the digital vitamins, minerals, and supplements space, marks a significant step in our journey to empower consumers to make informed choices and embrace wellness-focused products as part of their path to better health,” said Sharvil Patel, Chairman, Zydus Wellness.

Comfort Click’s portfolio includes three brands: WeightWorld, offering plant-based supplements and sports nutrition for adults; Maxmedix, a paediatric-focused gummy brand; and Animigo, which provides natural wellness solutions for pets.

Foray Into The VMS Market 

The deal marks Zydus Wellness’ entry into the fast-growing vitamins, minerals, and supplements (VMS) market. The global VMS market is projected to grow at a CAGR of 7% to 9% through 2030, reaching $50 billion to $60 billion, driven by rising health awareness and the expansion of e-commerce platforms. The European VMS market itself is estimated at GBP 11 billion, offering Zydus Wellness significant growth potential.

For updates and corrections, email newsroom[at]stocktwits[dot]com. <